International Clinical Trial: A Randomized, Open-label, Two-arm, Non-inferiority Clinical Study to Evaluate the Safety and Efficacy of Linezolid Tablets in the Treatment of Neurosyphilis

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122020) titled 'A Randomized, Open-label, Two-arm, Non-inferiority Clinical Study to Evaluate the Safety and Efficacy of Linezolid Tablets in the Treatment of Neurosyphilis' on April 8.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Hospital for Skin Diseases, Chinese Academy of Medical Sciences

Condition: Syphilis

Intervention: Linezolid Tablets Group:Linezolid Tablets Oral 600 mg every 12 hours for 14 days

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-05-01

Target Sample Size: Linezolid Tablets Group:60;Aqueous Crystalline Penicillin G sodium Group:60;

Cou...